Skip to content

Comparison Dilatation techniques in Percutaneous Nephrolithotomy

Comparison of Safety and Efficacy of One Shot and Telescopic Metal Dilatation in Percutaneous Nephrolithotomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201304095521N3
Enrollment
100
Registered
2013-05-05
Start date
2012-12-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

renal stone. Calculus of kidney

Interventions

Intervention 1: Intervention: One Shot Dilatation was performed inested of current telescopic dilatation in Percutaneous Nephrolithotomy. Intervention 2: Control: current Telescopic Metal Dilatation w
Treatment - Surgery
Intervention: One Shot Dilatation was performed inested of current telescopic dilatation in Percutaneous Nephrolithotomy.
Control: current Telescopic Metal Dilatation was performed in Percutaneous Nephrolithotomy.

Sponsors

Vice chancellor for research and technology, Hamadan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: any patients with any size of stones with ASA physical status 1 or 2 that refer for PCNL. Exclusion criteria: any contraindication for PCNL such as uncorrectable bleeding tendency and acute infection; any co- morbidity like severe cardiopulmonary that PCNL is not advised by other specialists and the patients who refused the procedure.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Mean operation time. Timepoint: During operation. Method of measurement: Minute.;Mean X-ray exposure time. Timepoint: During operation. Method of measurement: Second.

Secondary

MeasureTime frame
Stone free rate. Timepoint: During and to one week latter. Method of measurement: Stone free above 4 mm with KUB, sonography or CT scan.;Mean hemoglobin drop. Timepoint: One day aftre the operation. Method of measurement: gr/dl.;Blood transfusion rate. Timepoint: One day after operation. Method of measurement: Patients number that received blood.;Intraoperative bleeding. Timepoint: End of operation. Method of measurement: Resorvier blood/ mililiter.;Kidney and pelvis injury. Timepoint: During operation. Method of measurement: Diagnosis at operation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactIloon Kashkouli Abdolmajid

Hamadan University of Medical Sciences

ilounmajid@yahoo.com+98 81 1838 0704

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026